Insurance companies want proof that Wegovy is medically necessary. They may ask for records showing your weight, past weight-loss attempts, and any health conditions related to obesity. If these details aren’t included, they might refuse to cover it. This is why many people struggle with prior authorization.
The good news is that you can get approved faster by submitting everything correctly the first time. This article will guide you through the process of requesting a prior authorization for Wegovy, from gathering the proper paperwork to handling insurance delays. By following these steps, you’ll have a better chance of getting your Wegovy prescription covered without unnecessary waiting.
Is Wegovy Covered By Insurance?
Yes, but most, if not all, US insurance providers require prior authorization (PA) before covering Wegovy. This is due to its cost and specific FDA-approved uses. A PA means your doctor must provide evidence to your insurer that the medication is medically necessary and that you meet the required criteria.
To get approval, you must clearly show that you meet all eligibility requirements and that your use of Wegovy aligns with clinical recommendations.
How to Get Approved for Wegovy?
To receive Wegovy coverage, you must meet the required clinical criteria, which depend on whether you’re seeking coverage for weight loss or cardiovascular risk reduction.
Wegovy Criteria For Weight Loss
Wegovy is covered for weight loss if all the following criteria are met:
1. Age, BMI, and Comorbidities
You may qualify for Wegovy if:
-
- You are 12 years or older with a BMI of 30 or higher (classified as obesity), or
- You are an adult with a BMI of at least 27 and have at least one weight-related health condition.
This means that for adults 18 years and older with a BMI between 27 and 29.9, eligibility depends on having a significant obesity-related condition, such as:
-
- Type 2 diabetes
- High blood pressure (hypertension)
- High cholesterol or abnormal lipid levels (dyslipidemia)
- Obstructive sleep apnea
If you’re between 12 and 17 years old and have a BMI below 30 (meaning you are overweight but not classified as obese), you may not qualify. Insurance approval for pediatric patients requires a diagnosis of obesity, not overweight.
2. Lifestyle Intervention
Insurers typically require proof that you have attempted other weight-loss strategies before starting Wegovy. You must have participated in a structured weight management program for at least six months before submitting a request. This program should include:
-
- Behavioral modifications
- A reduced-calorie diet
- Increased physical activity
- Ongoing follow-ups
Some insurers may also require documentation of adherence to a structured dietary plan. This may include:
-
- Food diaries demonstrating a caloric deficit often requiring a daily 500-calorie deficit
- Exercise logs, step tracker reports, or gym attendance records
- Fitness app participation or reports showing at least 10,000 daily steps or 150 minutes of moderate exercise per week
These requirements ensure that Wegovy is being used as a next step rather than a first-line treatment.
3. Step Therapy
Many insurance plans require you to try and fail on a less expensive weight loss medication before approving Wegovy. These medications may include:
-
- Phentermine
- Orlistat (Xenical)
- Phentermine-topiramate (Qsymia)
For example, Aetna Medicare Better Health considers a medication trial unsuccessful if:
-
- Benzphetamine, diethylpropion, phendimetrazine, or phentermine – You do not lose at least 10 lbs after three months.
-
- Orlistat – You do not lose 10 lbs after six months.
-
- Saxenda (GLP-1 receptor agonist) – You do not achieve a 5% reduction in body weight after six months.
Your doctor will also need to submit a copy of your current weight-loss plan, including recent height and weight measurements, to ensure the PA request meets all required criteria.
Wegovy Criteria For MACE Reduction
Insurance may approve Wegovy to reduce the risk of MACE, such as heart attack or stroke, if all the following conditions are met:
1. Age and Medical History Documentation
You must be 45 years or older to qualify, have a BMI of 27 kg/m² or higher, and have established cardiovascular disease, as evidenced by one of the following:
-
- Prior myocardial infarction (heart attack)
- Prior ischemic or hemorrhagic stroke
- Symptomatic peripheral arterial disease (PAD), with supporting evidence such as:
-
-
- An ankle-brachial index < 0.85
- Prior revascularization
- Amputation due to atherosclerosis
-
2. Required Medications
You must already be on standard treatments unless you have a contraindication or intolerance. These include:
| Heart Attack | Stroke | Symptomatic Peripheral Arterial Disease (PAD) |
|---|---|---|
|
|
|
However, insurers may deny Wegovy for cardiovascular risk reduction if:
-
- You have diabetes with an HbA1c greater than 6.5%.
- You have severe heart failure (New York Heart Association Class IV).
If all criteria are met, your PA request for Wegovy is more likely to be approved.
How to Get Prior Authorization for Wegovy?
Securing prior authorization for Wegovy requires several steps that you and your doctor must complete.
1. Check Wegovy Coverage and PA Requirements
Start by confirming whether your insurance plan covers Wegovy and what the specific PA requirements are. You or your doctor can contact your insurer directly or check your plan’s formulary document to see if Wegovy is listed and flagged for prior authorization.
Understanding these requirements ahead of time allows your doctor to gather the necessary documentation. If Wegovy isn’t covered under your plan’s formulary, your doctor may explore filing a formulary exception or discuss alternative medications that might be covered instead.
2. Gather Required Medical Documentation
Next, your doctor will compile all the necessary medical details to support your PA request. This typically includes:
-
- Your height, weight, and BMI
- Your obesity diagnosis (with the appropriate ICD-10 code, such as E66.01 for morbid obesity)
- Any related health conditions (with corresponding diagnosis codes)
If Wegovy is being prescribed for MACE risk reduction, your doctor must also provide documentation of cardiovascular disease and relevant clinical history.
Listing any comorbid conditions can further support the medical necessity of Wegovy. The more comprehensive the documentation, the stronger your PA submission will be.
3. Submit the Prior Authorization Request
Depending on your insurance provider’s process, your doctor will then complete and submit the required PA form, either electronically or via fax. Many insurers use electronic prior authorization (ePA) systems through electronic health records or web portals, while some still require paper submissions.
4. Wait for a Decision
Processing times vary. Some automated systems may approve requests within minutes or hours if all criteria are clearly met. Standard reviews typically take a few days, with most decisions made within one to five business days.
By law, Medicare Part D and many commercial plans must respond within 72 hours for standard requests, or sooner if the request is urgent. More complex cases, especially those requiring additional information, can take up to two weeks.
5. Approval and Prescription Fulfillment
Once approved, you can fill your prescription at the pharmacy with your insurance covering its portion of the cost. Approval usually comes with a set duration and/or quantity limit. For instance, coverage for 12 months with up to four pens per 28 days.
What Should You Do if Your Prior Authorization for Wegovy is Denied?
If your insurer denies your prior authorization request for Wegovy, you have the right to challenge the decision through an appeal. Approximately 6% of prior authorization requests are denied, but only 11% of those denials are appealed. Many patients and healthcare providers are unaware that they can challenge an insurance denial.
This process allows you to present additional evidence to justify why the medication is medically necessary and request a reconsideration.
Here’s what you need to do:
1. Review the Denial Letter
After a denial, your insurance provider will send a notification, often an Explanation of Benefits (EOB) or denial letter, outlining the reason. Denials for Wegovy typically occur due to the following reasons:
Not Medically Necessary
Insurance companies may deny coverage if they believe Wegovy is not essential for your health or does not align with standard treatment guidelines. This often happens if:
-
- Your doctor did not clearly explain why Wegovy is medically necessary for you.
- The insurer’s coverage policies differ from your doctor’s clinical judgment.
- Incorrect billing or diagnostic codes were used.
Examples of ICD-10-CM diagnosis codes that may support a Wegovy prior authorization request include:
-
- E66.01 (Morbid obesity due to excess calories)
- E66.09 (Other obesity due to excess calories)
- E66.2 (Obesity hypoventilation syndrome)
- Z68.41 – Z68.45 (BMI of 40 or greater, depending on specific BMI range)
- I25.2 (Old myocardial infarction) – when Wegovy is prescribed to reduce cardiovascular risk
Experimental or Unproven Treatment
Insurance companies sometimes deny coverage for treatments they consider experimental or not widely accepted. Although Wegovy is FDA-approved for weight loss and reducing cardiovascular risk, insurers may still question its necessity in certain cases.
Common reasons include:
-
- Use outside FDA-approved indications: Insurers may deny coverage if you do not meet the BMI criteria or have not attempted other weight-loss methods first.
-
- Insufficient documentation: If the insurer believes Wegovy is not proven effective for your condition, additional supporting evidence may be required.
Understanding why your request was rejected is key to determining your next steps. Some denials are based on administrative errors, such as missing paperwork, which may be corrected by resubmitting the request with the required documents. Others stem from eligibility criteria you may not have met.
If the issue is a lack of documentation, your doctor can submit a revised request with the necessary records. For example, if proof of a six-month supervised weight loss program was omitted, adding that information in the appeal might resolve the issue.
2. Initiate an Internal Appeal
Your first step in challenging the denial is filing an internal appeal, which gives your insurance company another chance to review the request, this time with any additional evidence.
Your denial letter will include appeal instructions and deadlines, which typically range from 60 to 180 days for private insurers. Medicare Part D and Advantage plans follow a different appeal timeline.
Work with your doctor to prepare a strong case. A detailed appeal letter should include the following details:
-
- Your name and insurance policy number
- The authorization or claim number
- The date of your initial prior authorization request
- The reason given for the denial
- A formal request for the insurance company to reconsider the decision
- A statement from your doctor explaining why Wegovy is necessary, including clinical evidence and references to medical guidelines
- Any relevant medical records demonstrating that you meet the criteria for coverage
- A concluding statement from your doctor emphasizing the importance of Wegovy for your health
- Your doctor’s signature, date, and contact information
Additionally, you may include a personal statement explaining how Wegovy would impact your health and quality of life.
Appeals are often successful. Data from the US Government Accountability Office shows that insurers reverse their original denial in 39% to 59% of internal appeals.
3. Consider a Peer-to-Peer Review
If your appeal is still under review, your doctor may be able to request a peer-to-peer discussion with the insurance company’s medical reviewer.
This is an informal conversation between your doctor and an insurance physician or pharmacist to clarify the case and provide any additional details that may help overturn the denial. Although this isn’t an official appeal, it can sometimes resolve coverage issues or clarify what further documentation is needed for approval.
4. Apply for a Second-Level Appeal or Higher-Level Appeals (if needed)
If your initial appeal is denied, you still have options. Most insurance companies allow multiple levels of appeal, and your denial letter will provide instructions on how to proceed.
For those on Medicare, the appeals process follows multiple levels, including:
-
- Redetermination
- Reconsideration by an Independent Review Entity
- A hearing with an Administrative Law Judge (for Medicare Part D or Advantage denials)
If all internal appeals fail, you may qualify for an external review by an independent third-party organization. This review may:
-
- Uphold the insurer’s denial or
- Overturn the denial, requiring the insurer to cover Wegovy. If the appeal is approved at this level, the insurance company must comply with the decision.
If you believe the denial is unjustified, you can file a complaint with your state’s Department of Insurance. In extreme cases, legal action may be an option, though it is generally considered a last resort.
Persistence and thorough documentation significantly improve your chances of getting approval for Wegovy. Follow each step carefully and provide strong evidence to support your case.
Explore Financial Assistance Options
While waiting for approval or during an appeal, consider financial assistance programs to help reduce costs. Novo Nordisk, the manufacturer of Wegovy, offers a savings card and other patient support programs. Additionally, other options may be available, including:
-
- Switch to a Covered Alternative: If your insurance does not cover Wegovy, ask your doctor about alternative medications for weight management or cardiovascular risk reduction that may be covered, such as Saxenda or other GLP-1 receptor agonists.
-
- Explore Discount Pharmacies or Coupons: Look into prescription savings programs such as GoodRx, SingleCare, or Blink Health to find lower prices at local or online pharmacies.
-
- Buy From Canadian Pharmacies: At Pharma Giant, an online platform partnering with licensed Canadian pharmacies, you can find Wegovy starting at $609.99–significantly lower than prices at US pharmacies. It’s the same trusted, FDA-approved Wegovy, just more affordable due to Canada’s strict drug pricing regulations.
-
- Apply for Financial Assistance: Nonprofit organizations and patient assistance programs, such as the PAN Foundation or NeedyMeds, may offer financial aid for medications like Wegovy. Check their eligibility criteria to see if you qualify for support.
Summary
Wegovy may be covered by insurance, but prior authorization is required. Approval depends on meeting strict criteria, including BMI, health conditions, and documented weight-loss efforts. Thorough documentation improves your chances, and if denied, you can appeal by submitting more evidence or requesting a review.
If insurance won’t cover Wegovy, consider savings programs, discount pharmacies, or purchasing from licensed Canadian pharmacies like Pharma Giant for lower prices. Staying persistent and following the right steps can help you secure coverage.
Frequently Asked Questions
Related Articles
Sources
GAO. (2011). Data on Application and Coverage Denials – PRIVATE HEALTH INSURANCE. Retrieved from https://www.gao.gov/assets/gao-11-268.pdf
Blue Cross Blue Shield of Michigan (2025). Prior authorization and step therapy coverage criteria. Retrieved from https://www.bcbsm.com/amslibs/content/dam/public/consumer/forms-documents/pharmacy/prior-authorization-and-step-therapy-guidelines.pdf
Aetna Better Health. (2024). VA FIDE Medicaid Weight Loss Drug Prior Authorization Criteria. Retrieved from https://www.aetnabetterhealth.com/content/dam/aetna/medicaid/pdfs/formulary-updates/2025/H1610_3946498_2025_C_remediation.pdf
UnitedHealthcare Pharmacy. (2024). Prior Authorization/Notification – Plans with Weight Loss Medication Coverage. Retrieved from https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/drugs-pharmacy/commercial/r-z/PA-Notification-Weight-Loss.pdf
CVS Caremark. (2021). PRIOR AUTHORIZATION CRITERIA-WEGOVY. Retrieved from https://www.shpnc.org/documents/files/wegovy/open
